bromodeoxyuridine has been researched along with Benign Cerebellar Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cavallaro, S; Ceccarelli, M; Cinà, I; Ciotti, MT; De Bardi, M; Di Rocco, C; Farioli-Vecchioli, S; Leonardi, L; Micheli, L; Pallini, R; Tirone, F | 1 |
| Davis, RL; Edwards, MS; Onda, K | 1 |
| Isoe, S; Kawaoi, A; Kimura, R; Naganuma, H; Nakano, S; Nukui, H; Sasaki, A; Suzuki, K | 1 |
| Edwards, MS; Hoshino, T; Ito, S; Prados, MD | 1 |
| Guérin, J; Maire, JP; San-Galli, F | 1 |
| Davis, RL; Edwards, MS; Hoshino, T; Murovic, JA; Nagashima, T | 1 |
1 review(s) available for bromodeoxyuridine and Benign Cerebellar Neoplasms
| Article | Year |
|---|---|
[Medulloblastoma: towards new prognostic factors].
Topics: Antibodies, Monoclonal; Bromodeoxyuridine; Cerebellar Neoplasms; Chromosome Aberrations; Chromosome Disorders; DNA, Neoplasm; Flow Cytometry; Humans; Medulloblastoma; Neoplasm Invasiveness; Neurobiology; Phenotype; Prognosis | 1991 |
5 other study(ies) available for bromodeoxyuridine and Benign Cerebellar Neoplasms
| Article | Year |
|---|---|
Tis21 knock-out enhances the frequency of medulloblastoma in Patched1 heterozygous mice by inhibiting the Cxcl3-dependent migration of cerebellar neurons.
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Bromodeoxyuridine; Cell Count; Cell Movement; Cell Proliferation; Cerebellar Neoplasms; Cerebellum; Chemokines, CXC; Genetic Vectors; Genotype; Heterozygote; Immediate-Early Proteins; Immunohistochemistry; Immunoprecipitation; In Situ Hybridization; Medulloblastoma; Mice; Mice, Inbred C57BL; Mice, Knockout; Microarray Analysis; Neurons; Patched Receptors; Patched-1 Receptor; Real-Time Polymerase Chain Reaction; Receptors, Cell Surface; Retroviridae; Tumor Suppressor Proteins | 2012 |
Comparison of bromodeoxyuridine uptake and MIB 1 immunoreactivity in medulloblastomas determined with single and double immunohistochemical staining methods.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Bromodeoxyuridine; Cerebellar Neoplasms; Child; Child, Preschool; Female; Humans; Immunohistochemistry; Male; Medulloblastoma; Recurrence; Regression Analysis; Staining and Labeling | 1996 |
Proliferating cell nuclear antigen (PCNA) immunostaining as an alternative to bromodeoxyuridine (BrdU) immunostaining for brain tumours in paraffin embedded sections.
Topics: Antigens, Neoplasm; Astrocytoma; Biomarkers, Tumor; Brain; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Cerebellar Neoplasms; Craniotomy; Glioblastoma; Humans; Immunoenzyme Techniques; Infusions, Intravenous; Medulloblastoma; Meningeal Neoplasms; Meningioma; Neoplasm Recurrence, Local; Neurilemmoma; Nuclear Proteins; Proliferating Cell Nuclear Antigen | 1992 |
Cell kinetics of medulloblastomas.
Topics: Adolescent; Adult; Autoradiography; Bromodeoxyuridine; Cerebellar Neoplasms; Child; Child, Preschool; Female; Humans; Idoxuridine; Immunoenzyme Techniques; Infant; Male; Medulloblastoma; Neoplasm Recurrence, Local; S Phase; Survival Analysis | 1992 |
Pediatric central nervous system tumors: a cell kinetic study with bromodeoxyuridine.
Topics: Adolescent; Astrocytoma; Brain; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Cerebellar Neoplasms; Child; Child, Preschool; DNA, Neoplasm; Female; Glioblastoma; Humans; Immunoenzyme Techniques; Infant; Male; Medulloblastoma; Prognosis | 1986 |